Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy

L. Mortara, E. Balza, A. Bruno, A. Poggi, P. Orecchia, B. Carnemolla

Research output: Contribution to journalArticle

Original languageUndefined/Unknown
Pages (from-to)2905
Number of pages1
JournalFrontiers in Immunology
Volume9
DOIs
Publication statusPublished - 2018

Cite this

Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy. / Mortara, L.; Balza, E.; Bruno, A.; Poggi, A.; Orecchia, P.; Carnemolla, B.

In: Frontiers in Immunology, Vol. 9, 2018, p. 2905.

Research output: Contribution to journalArticle

@article{83d94da935064b8b8955b82bbbb6dc9b,
title = "Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy",
author = "L. Mortara and E. Balza and A. Bruno and A. Poggi and P. Orecchia and B. Carnemolla",
note = "cited By 0",
year = "2018",
doi = "10.3389/fimmu.2018.02905",
language = "Non definita",
volume = "9",
pages = "2905",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S.A.",

}

TY - JOUR

T1 - Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy

AU - Mortara, L.

AU - Balza, E.

AU - Bruno, A.

AU - Poggi, A.

AU - Orecchia, P.

AU - Carnemolla, B.

N1 - cited By 0

PY - 2018

Y1 - 2018

U2 - 10.3389/fimmu.2018.02905

DO - 10.3389/fimmu.2018.02905

M3 - Articolo

VL - 9

SP - 2905

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

ER -